The SHL Perspective

Empowering Innovation

Maggie® is an easy-to-use, cartridge-based autoinjector built with SHL’s proprietary Needle Isolation Technology (NIT®). Requiring just two simple steps to operate, Maggie® opens  up pathways for larger fill  volumes and an enhanced  injection experience.

Feb 5-6 Paris, France

Booth C64

Learn more at 2020 Pharmapack Europe

Maggie®

Transform your cartridge-based treatment with Maggie®, a two-step autoinjector built with SHL’s proprietary Needle Isolation Technology (NIT®).

Needle Isolation Technology

Close

NIT® is a unique safety solution that makes it possible for cartridges to function like traditional pre-filled syringes with staked needles. Cartridges support higher volume dosing and enable dual-chamber treatments to be built as easy-to-use autoinjectors.

Higher Volume Injections

Close

Maggie® is built with a 3mL standard ISO cartridge to support the growing trend for high-volume dosing with the emergence of biologics and biosimilars. Cartridges also offer a level of needle customization for subcutaneous or intramuscular injections.

Automated Preparation

Close

Maggie®’s NIT® sub-assembly includes a pre-attached needle. Users simply untwist the cap to attach the needle and open the fluid path. The needle cover automatically extends and the autoinjector automatically primes.

Easy 2-Step Handling

Close

Injection with Maggie® is completed with just two simple steps: uncap and inject. The autoinjector needle cover locks out after injection, shielding patients from being exposed to the needle before and after injection.

Intuitive Feedback

Close

Maggie®’s large viewing window makes it easier for patients to inspect the drug before and during injection. It also features continuous audible clicks during injection, resulting in an easier determination of dose completion.

Intuitive Feedback

Maggie®’s large viewing window makes it easier for patients to inspect the drug before and during injection. It also features continuous audible clicks during injection, resulting in an easier determination of dose completion.

Easy 2-Step Handling

Injection with Maggie® is completed with just two simple steps: uncap and inject. The autoinjector needle cover locks out after injection, shielding patients from being exposed to the needle before and after injection.

Automated Preparation

Maggie®’s NIT® sub-assembly includes a pre-attached needle. Users simply untwist the cap to attach the needle and open the fluid path. The needle cover automatically extends and the autoinjector automatically primes.

Higher Volume Injections

Maggie® is built with a 3mL standard ISO cartridge to support the growing trend for high-volume dosing with the emergence of biologics and biosimilars. Cartridges also offer a level of needle customization for subcutaneous or intramuscular injections.

Needle Isolation Technology

NIT® is a unique safety solution that makes it possible for cartridges to function like traditional pre-filled syringes with staked needles. Cartridges support higher volume dosing and enable dual-chamber treatments to be built as easy-to-use autoinjectors.

© 2019 SHL Medical AG. SHL, the SHL logo, and all other trademarks are property of SHL Medical AG and/or its affiliates.

Go to article: Home | Access denied: the Impact trial Go to article: Scandinavian Health Ltd.Go to article: In this issueGo to article: Emirates SkyCargoGo to article: ContentsGo to article: NewsGo to article: FargoGo to article: The pharma industry briefingGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: Breast cancer timeline: charting three decades of successGo to article: PrEP drugs: is the NHS letting down patients at risk of HIV?Go to article: Swiss WorldCargoGo to article: Debate: can US pharma be taxed into behaving?Go to article: LB Bohle Company Insight Go to article: LB BohleGo to article: Can new therapies tackle the burden of endometriosis?Go to article: The rise of fake medicines in AfricaGo to article: Zenatek Go to article: Off-the-shelf CAR-T therapy: broadening the reach of precision medicineGo to article: Nobel Prize 2019: how a breathtaking discovery unlocked new drugsGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: China in 2019: a prime destination for R&D deals Go to article: The global-local continuum: tips for a joined-up approach to Regulatory & PV outGo to article: Pharmacovigilance 2.0: reskilling for the digital & data science ageGo to article: Air France KLM Cargo Go to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue